Resolute Advisors LLC Dexcom Inc Transaction History

Resolute Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $3,896 - $4,884	-30 Closed	0 $0
Q2 2021 Dec 27, 2021	BUY	$80.99 - $107.93 $2,429 - $3,237	30 New	30 $13,000
Q1 2021 May 17, 2021	SELL	$84.79 - $104.74 $254 - $314	-3 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $234 - $313	3 New	3 $1,000

1,084

352M

8.45M

5.75M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $33.2B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Resolute Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Resolute Advisors LLC with notifications on news.